Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Organon & Co. & Sun Pharma

7 shared events · Importance 3 · Last updated May 21, 2026

Importance
3
Shared Events
7
Actions
2
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
95
Business
Organon & Co.: Organon is the target of Sun Pharma's acquisition. The deal is expected to close by March 2027, and Organon is projected to contribute 40-45% of the combined group's EBITDA, enhancing Sun Pharma's scale and geographic reach.
Sun Pharma: Sun Pharma is the subject of the rating actions and the acquirer in the USD 11.75 billion Organon deal. The investment-grade ratings and expected revenue growth to about USD 14 billion by FY28 strengthen its credit profile and market position.
Sep 08, 2026 · 6 articles
77
Business
Organon & Co.: Organon shareholders approved the proposed acquisition by Sun Pharma, which is on track to close in early 2027, expected to strengthen Sun's specialty portfolio.
Sun Pharma: Sun Pharma reported a 27% rise in Q1 net profit and 10.5% revenue growth, driven by India and innovative medicines, while US generics declined. The company is progressing on its Organon acquisition, expected to close in early 2027.
Jul 31, 2026 · 7 articles
46
Domestic
Organon & Co.: Organon & Co. is the target of Sun Pharma's $11.75 billion acquisition, which is reinforced by Sun's U.S. pricing agreement and tariff relief.
Sun Pharma: Sun Pharma extended MFN pricing to United States — Medicaid and future launches, gaining a two-year tariff reprieve. The deal supports its planned $11.75 billion acquisition of Organon & Co., though shares dipped about 1%.
Aug 18, 2026 · 37 articles
5
Business
Organon & Co.: Acquired by Sun Pharma in 2026; mentioned as comparable deal.
Sun Pharma: Mentioned as part of 2026 M&A activity; acquired Organon for $11.75B.
Jul 06, 2026 · 34 articles
0
Business
Organon & Co.: Organon & Co. is the target of a significant acquisition by Sun Pharma, showcasing outbound M&A from India.
May 21, 2026 · 6 articles
0
Business
Apr 26, 2026 · 28 articles
0
Domestic
Apr 27, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Organon & Co. and Sun Pharma interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.